Condition

Metastatic Urothelial Cancer (1)

Unresectable Locally Advanced Urothelial Cancer (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

AstraZeneca (1)

Collaborator

Intervention

carboplatin + gemcitabine (1)

cisplatin + gemcitabine (1)

durvalumab (1)

tremelimumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

unresectable locally advanced urothelial cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Unresectable Locally Advanced Urothelial Cancer, Metastatic Urothelial Cancer Trial in Worldwide (Durvalumab, Tremelimumab,

Recruiting

Unresectable Locally Advanced Urothelial Cancer
Metastatic Urothelial Cancer

Durvalumab
+3 more

Birmingham, Alabama
+237 more

Aug 18, 2022